Current Therapeutic Options for Alzheimer’s Disease

por Lleó, Alberto
Publicado 2007

Biomarkers in neurological disorders: a fast-growing market

por Lleó, Alberto
Publicado 2021

The cognitive aftermath of COVID-19

por Lleó, Alberto, Alcolea, Daniel
Publicado 2020

Race and Alzheimer Disease Biomarkers: A Neglected Race

por Lleó, Alberto, Suárez-Calvet, Marc
Publicado 2021

Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer’s Disease

por Perea, Juan R., Lleó, Alberto, Alcolea, Daniel, Fortea, Juan, Ávila, Jesús, Bolós, Marta
Publicado 2018

Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer’s disease

por Barranco, Neus, Plá, Virginia, Alcolea, Daniel, Sánchez-Domínguez, Irene, Fischer-Colbrie, Reiner, Ferrer, Isidro, Lleó, Alberto, Aguado, Fernando
Publicado 2021

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum

por Goossens, Julie, Cervantes González, Alba, Dewit, Nele, Lidón, Laia, Fortea, Juan, Alcolea, Daniel, Lleó, Alberto, Belbin, Olivia, Vanmechelen, Eugeen
Publicado 2023

The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production

por Badiola, Nahuai, Alcalde, Victor, Pujol, Albert, Münter, Lisa-Marie, Multhaup, Gerd, Lleó, Alberto, Coma, Mireia, Soler-López, Montserrat, Aloy, Patrick
Publicado 2013

Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer’s disease

por Sogorb-Esteve, Aitana, García-Ayllón, María-Salud, Fortea, Juan, Sánchez-Valle, Raquel, Lleó, Alberto, Molinuevo, José-Luis, Sáez-Valero, Javier
Publicado 2016

YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies

por Querol-Vilaseca, Marta, Colom-Cadena, Martí, Pegueroles, Jordi, San Martín-Paniello, Carla, Clarimon, Jordi, Belbin, Olivia, Fortea, Juan, Lleó, Alberto
Publicado 2017

New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

por del Campo, Marta, Zetterberg, Henrik, Gandy, Sam, Onyike, Chiadi U, Oliveira, Fabricio, Udeh‐Momoh, Chi, Lleó, Alberto, Teunissen, Charlotte E., Pijnenburg, Yolande
Publicado 2022

Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease

por Vilaplana, Eduard, Rodriguez-Vieitez, Elena, Ferreira, Daniel, Montal, Victor, Almkvist, Ove, Wall, Anders, Lleó, Alberto, Westman, Eric, Graff, Caroline, Fortea, Juan, Nordberg, Agneta
Publicado 2020

Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study

por Pentz, Rowan, Iulita, M. Florencia, Ducatenzeiler, Adriana, Videla, Laura, Benejam, Bessy, Carmona‐Iragui, María, Blesa, Rafael, Lleó, Alberto, Fortea, Juan, Cuello, A. Claudio
Publicado 2020

Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemia

por Sampedro, Frederic, Stantonyonge, Nicole, Martínez-Horta, Saül, Alcolea, Daniel, Lleó, Alberto, Muñoz, Laia, Pérez-González, Rocío, Marín-Lahoz, Juan, Gómez-Ansón, Beatriz, Chico, Ana
Publicado 2020

Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy

por Badiola, Nahuai, de Oliveira, Rita Machado, Herrera, Federico, Guardia-Laguarta, Cristina, Gonçalves, Susana A., Pera, Marta, Suárez-Calvet, Marc, Clarimon, Jordi, Outeiro, Tiago Fleming, Lleó, Alberto
Publicado 2011

Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease

por Siedlecki-Wullich, Dolores, Català-Solsona, Judit, Fábregas, Cristina, Hernández, Isabel, Clarimon, Jordi, Lleó, Alberto, Boada, Merce, Saura, Carlos A., Rodríguez-Álvarez, José, Miñano-Molina, Alfredo J.
Publicado 2019

AMYQ: An index to standardize quantitative amyloid load across PET tracers

por Pegueroles, Jordi, Montal, Victor, Bejanin, Alexandre, Vilaplana, Eduard, Aranha, Mateus, Santos‐Santos, Miguel Angel, Alcolea, Daniel, Carrió, Ignasi, Camacho, Valle, Blesa, Rafael, Lleó, Alberto, Fortea, Juan
Publicado 2021

Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles

por Delaby, Constance, Alcolea, Daniel, Hirtz, Christophe, Vialaret, Jérôme, Kindermans, Jana, Morichon, Lisa, Fortea, Juan, Belbin, Olivia, Gabelle, Audrey, Blennow, Kaj, Zetterberg, Henrik, Lleó, Alberto, Lehmann, Sylvain
Publicado 2022

Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross‐platform validation study

por Hok‐A‐Hin, Yanaika S., Bolsewig, Katharina, Ruiters, Daimy N., Lleó, Alberto, Alcolea, Daniel, Lemstra, Afina W., van der Flier, Wiesje M., Teunissen, Charlotte E., del Campo, Marta
Publicado 2023

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease

por García-Ayllón, María-Salud, Lopez-Font, Inmaculada, Boix, Claudia P., Fortea, Juan, Sánchez-Valle, Raquel, Lleó, Alberto, Molinuevo, José-Luis, Zetterberg, Henrik, Blennow, Kaj, Sáez-Valero, Javier
Publicado 2017